KRAS ((G12D) ASP3082

Tomohiro Yoshinari1, Takeyuki Nagashima2, Hiroki Ishioka2

  • 1Engineered Small Molecules, Astellas Pharma Inc., Tsukuba, Japan. tomohiro.yoshinari@astellas.com.

Communications chemistry
|August 23, 2025
PubMed
概括

研究人员开发了ASP3082,一种针对癌症常见的KRAS (G12D) 突变的新型降解剂. 这种化合物有效降解KRAS(G12D) 蛋白质,有望治疗KRAS(G12D) 突变的癌症.